TABLE 5.
Characteristics | Dead n = 32 (%) | Alive n = 100 (%) | P value | Adjusted OR (95% CI)a | P valueb |
---|---|---|---|---|---|
Male gender | 22 (68.8) | 63 (63) | 0.55 | 0.67 (0.24–1.90) | 0.462 |
Age (yrs) (median, IQR) | 55 (18–79) | 54 (18–90) | 0.73 | 0.60 (0.2–1.60) | 0.309 |
Inadequate empirical antibiotic therapy | 21 (63.6) | 41 (41.4) | 0.027 | 2.73 (1.11–6.68) | 0.028 |
Therapy with ceftolozane-tazobactam | 3 (9.4) | 41 (41) | 0.001 | 0.16 (0.04–0.58) | 0.006 |
Persistent bloodstream infection | 9 (30) | 13 (13.1) | 0.031 | 2.13 (0.73–6.21) | 0.16 |
OR, odds ratio; 95% CI, 95% confidence interval.
Bold formatting indicates statistical significance.